Accessibility Tools
Book Now

Thank you for choosing TeleSlim Clinic in Illinois!

We accept cash-pay patients in Illinois — no insurance hassles.

Choose an option below to get started.

X
Close

Semaglutide vs Tirzepatide: Which Weight Loss Medication Is Right for You?

Semaglutide and tirzepatide are the two most widely used injectable weight loss medications. Both are taken weekly and both reduce appetite, but they work differently and have different trial results. This guide compares them so you can have an informed conversation with your clinician.

Important safety information. This page is general education, not medical advice. Only a licensed clinician who knows your history can decide whether a medication is right for you. Do not start, stop or change a prescription without talking to your clinician. If you have severe abdominal pain, trouble breathing, swelling of the face or throat, or thoughts of harming yourself, seek emergency care or call 988.

Book your free visit →

Side-by-Side Overview

Feature Semaglutide Tirzepatide
How it works Activates GLP-1 receptors Activates GLP-1 and GIP receptors
Weight-loss brand Wegovy Zepbound
How it is taken Weekly injection (a daily pill form is also available) Weekly injection
Maintenance dose 2.4 mg weekly (injection) 5, 10 or 15 mg weekly
Boxed warning Thyroid C-cell tumors (animal studies) Thyroid C-cell tumors (animal studies)

What the Research Shows

In the SURMOUNT-5 head-to-head trial in adults with obesity, tirzepatide produced an average weight loss of about 20% over 72 weeks, compared with about 14% for semaglutide. Individual results vary widely, and the best medication for you also depends on side effects, other health conditions, cost and coverage.

Side Effects

The most common side effects of both medications are stomach-related: nausea, diarrhea, vomiting and constipation, mostly during dose increases. Both carry a boxed warning for thyroid C-cell tumors seen in animals and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. Tirzepatide can reduce the effectiveness of oral birth control pills.

How to Decide

  • Your health history: heart disease, sleep apnea, liver disease or diabetes may favor one option.
  • Your goals: how much weight you want to lose and how fast.
  • Tolerability: how you respond to dose increases.
  • Cost and coverage: insurance rules and cash-pay options differ. See our medication cost guide.

Frequently Asked Questions

Is tirzepatide stronger than semaglutide?

In head-to-head research, average weight loss was higher with tirzepatide. That does not mean it is better for every person.

Can I switch from one to the other?

Some people switch under clinician guidance. Do not combine them or change doses on your own.

Which one is covered by insurance?

Coverage varies by plan. Check your plan and our Cost & Insurance guides.

How TeleSlim Clinic Can Help

A TeleSlim Clinic physician can review your health history and goals by secure video visit and discuss whether prescription weight loss treatment is appropriate for you. Prescribing is always at the clinician's discretion, and not every medication is right for every person. See our Cost & Insurance guides and Illinois locations.

Cost & Insurance guides

TeleSlim Clinic visits are self-pay, and we do not bill insurance for our own services. We do handle prior authorization for your medication, provide a superbill you can submit to your insurance for possible reimbursement, and send your medication and lab orders to the pharmacy or lab you choose, where your insurance can be used. We do not see patients with Medicare.

More in This Library

Start Your Weight Loss Journey

Free visit available — book your free visit.

If you are considering bariatric surgery, learn about surgical options with Dr. Jihad Kudsi at DoctorKudsi.com (https://www.doctorkudsi.com).

Sources: FDA prescribing information for Wegovy and Zepbound; SURMOUNT-5 trial, New England Journal of Medicine 2025.

This page is general information, not medical advice. Prescribing information changes; confirm current details with your clinician or pharmacist. Last updated: October 7, 2026.